fda compounding semaglutide warning 2025 october is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA Decisions Expected: October 2025

The recommended dosage of Semaglutide GLP-1 is one injection per week, and your doctor will monitor your progress and adjust the dosage as needed

Compounding pharmacies cannot legally compound exact copies of FDA-approved drugs when those drugs are commercially available

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Zhang M., Yang B., Luan X., Jiang L., Lu C., Wu C., Pan X., Peng T

When to Consider Switching From Semaglutide to Tirzepatide You might benefit from transitioning if youve reached a weight loss plateau, are experiencing challenging side effects, have insurance coverage changes, or your provider recommends optimization based on your progress